HU914067D0 - New medical preparations for preventing gastric acid secretion and with gastrocitoprotective effect - Google Patents
New medical preparations for preventing gastric acid secretion and with gastrocitoprotective effectInfo
- Publication number
- HU914067D0 HU914067D0 HU406791A HU406791A HU914067D0 HU 914067 D0 HU914067 D0 HU 914067D0 HU 406791 A HU406791 A HU 406791A HU 406791 A HU406791 A HU 406791A HU 914067 D0 HU914067 D0 HU 914067D0
- Authority
- HU
- Hungary
- Prior art keywords
- gastrocitoprotective
- effect
- gastric acid
- acid secretion
- new medical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU406791A HU209245B (en) | 1991-12-20 | 1991-12-20 | Process for producing new cimetidine derivatives, as well as new gastric acid secretion inhibiting and gastrocytoprotective pharmaceuitcal compositions |
| PCT/HU1992/000059 WO1993012787A1 (en) | 1991-12-20 | 1992-12-18 | New pharmaceutical compositions inhibiting gastric acid secretion and exerting gastrocytoprotective effect |
| CN 92115369 CN1075255A (en) | 1991-12-20 | 1992-12-19 | The new pharmaceutical composition of gastric cells protective effect is secreted and had to gastric acid inhibitory |
| TW81110294A TW232015B (en) | 1991-12-20 | 1992-12-21 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU406791A HU209245B (en) | 1991-12-20 | 1991-12-20 | Process for producing new cimetidine derivatives, as well as new gastric acid secretion inhibiting and gastrocytoprotective pharmaceuitcal compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU914067D0 true HU914067D0 (en) | 1992-03-30 |
| HUT63955A HUT63955A (en) | 1993-11-29 |
| HU209245B HU209245B (en) | 1994-04-28 |
Family
ID=10966768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU406791A HU209245B (en) | 1991-12-20 | 1991-12-20 | Process for producing new cimetidine derivatives, as well as new gastric acid secretion inhibiting and gastrocytoprotective pharmaceuitcal compositions |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN1075255A (en) |
| HU (1) | HU209245B (en) |
| TW (1) | TW232015B (en) |
| WO (1) | WO1993012787A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20000022532A (en) * | 1996-06-27 | 2000-04-25 | 오노 야꾸힝 고교 가부시키가이샤 | Aryl (sulfide, sulfoxide and sulfone) derivatives and drugs containing the same as the active ingredient |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0040489A1 (en) * | 1980-05-17 | 1981-11-25 | FISONS plc | Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine |
| EP0156233A3 (en) * | 1984-03-19 | 1986-02-19 | Merck & Co. Inc. | Use of leukotriene antagonists for producing cytoprotective pharmaceutical compositions and process for producing cytoprotective pharmaceutical compositions |
| EP0389607A1 (en) * | 1988-09-14 | 1990-10-03 | Biota Scientific Management Pty. Ltd. | Chromone derivatives |
| HU203839B (en) * | 1989-07-14 | 1991-10-28 | Richter Gedeon Vegyeszet | Process for producing pharmaceutical composition containing acrylic acid derivatives |
-
1991
- 1991-12-20 HU HU406791A patent/HU209245B/en not_active IP Right Cessation
-
1992
- 1992-12-18 WO PCT/HU1992/000059 patent/WO1993012787A1/en active Application Filing
- 1992-12-19 CN CN 92115369 patent/CN1075255A/en active Pending
- 1992-12-21 TW TW81110294A patent/TW232015B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| CN1075255A (en) | 1993-08-18 |
| HUT63955A (en) | 1993-11-29 |
| HU209245B (en) | 1994-04-28 |
| TW232015B (en) | 1994-10-11 |
| WO1993012787A1 (en) | 1993-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2252158B (en) | Respiration monitor | |
| GB9016789D0 (en) | Medicament administering devices | |
| AU2186792A (en) | Patient sling | |
| HU9202085D0 (en) | Derivatives of 7-isoindolinyl-quinolone and of naphthyridone-carboxylic acid | |
| HU9201254D0 (en) | Rapamicine-carbamates and medical preparations containing them as active agents | |
| GB9125695D0 (en) | Medical preparations | |
| IL103294A0 (en) | Pharmaceutical compositions for preventing tissue damage associated with decreased blood flow | |
| GB8808758D0 (en) | Nutritional and medicinal compositions | |
| HU9302183D0 (en) | Medical preparatives for preventing and treating osteoporises after menopausa | |
| GB2255721B (en) | Medical devices | |
| HU914068D0 (en) | New gastrocitoprotective medical preparation for preventing gastric acid secretion | |
| AU3494293A (en) | Thiazolyl-pyridine derivatives and their use as gastric acid secretion inhibitors | |
| HU914067D0 (en) | New medical preparations for preventing gastric acid secretion and with gastrocitoprotective effect | |
| HU9204072D0 (en) | Terazole derivatives and medical preparatives containing them | |
| IL102099A0 (en) | Propenoic acid derivatives and their use as fungicides | |
| HU9200644D0 (en) | Medical preparatives | |
| ZA847975B (en) | Beta-elemonic acid and pharmaceutical preparations | |
| HU9203050D0 (en) | Thieno-cyclopentanole-oximes and pharmaceutical preparatives containing them | |
| GB9125962D0 (en) | Patient hoist | |
| GB9125761D0 (en) | Medical preparations | |
| IL99331A0 (en) | Difficult intubation devices and patient head positioning | |
| HU910416D0 (en) | Medical mattress | |
| HU913714D0 (en) | Medical preparation | |
| ZA914000B (en) | Use of local anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis | |
| EG19885A (en) | Medicament for the treatment of hyperlipidaemia and/or atherosolerosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HMM4 | Cancellation of final prot. due to non-payment of fee |